CSPC Innovation Pharmaceutical Co., Ltd. (SZSE: 300765)
Health Care · Pharmaceuticals · CN
CN¥49.00
+20.19% today · -9.7% 1Y
CSPC Innovation Pharmaceutical Co., Ltd. (SZSE: 300765) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.15B and employs 2,369 people.
Over the last twelve months the share price has lost 9.7%, trading between 22.50 and 60.00.
Tweenvest scores CSPC Innovation Pharmaceutical Co., Ltd. across four factors: quality 63/100, value 44/100, growth 60/100, dividend 8/100. Its strongest factor is quality.
300765 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.15B
- Revenue (TTM)
- $640.14M
- P/E
- 67.20
- EPS
- 0.73
- Dividend yield
- 0.04%
- Beta (5Y)
- -0.03
- 52-week high
- CN¥60.00
- 52-week low
- CN¥22.50
- Avg volume (3M)
- —
- Shares outstanding
- 1.39B
- Employees
- 2,369
- Next earnings
- —
About CSPC Innovation Pharmaceutical Co., Ltd.
Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company functions as a subsidiary of the larger entity, CSPC Pharmaceutical Group Limited.
- ISIN
- CNE100003K04
- Founded
- 2006
- Listed since
- Mar 22, 2019
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.